For research use only. Not for therapeutic Use.
Rolinsatamab is a potent dual IL-4 and IL-13 inhibitor as a fully humanized bispecific monoclonal antibody. Rolinsatamab chimeric antigen receptor sequence T cell. Rolinsatamab can be used in research of immune disease[1].
| Catalog Number | I043167 |
| CAS Number | 2095467-30-2 |
| Purity | ≥95% |
| Reference | [1]. Ray EL, et, al. Protease switch for dual targets chimeric antigen receptor t cell therapy. WO2021087245. |
